The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.
The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...
On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...
Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...
The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...
Agency commissioners voted unanimously on Tuesday to publish the report, which makes a similar attack on the drug middlemen ...
WASHINGTON >> The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain ...
CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal ...
The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback